BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8556513)

  • 1. A prospective study of antibody responses to defined epitopes of human papillomavirus (HPV) type 16 in relationship to genital and anorectal presence of HPV DNA.
    Van Doornum GJ; Prins M; Pronk L; Coutinho RA; Dillner J
    Clin Diagn Lab Immunol; 1994 Nov; 1(6):633-9. PubMed ID: 8556513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of immunoglobulin G antibodies against defined epitopes of the L1 and L2 capsid proteins of human papillomavirus type 6 are elevated in men with a history of condylomata acuminata.
    Wikström A; Eklund C; Von Krogh G; Lidbrink P; Dillner J
    J Clin Microbiol; 1992 Jul; 30(7):1795-800. PubMed ID: 1378454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of human papillomavirus seroconversions.
    Wikström A; van Doornum GJ; Quint WG; Schiller JT; Dillner J
    J Gen Virol; 1995 Mar; 76 ( Pt 3)():529-39. PubMed ID: 7897345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study on the development of antibodies against human papillomavirus type 6 among patients with condyloma acuminata or new asymptomatic infection.
    Wikström A; van Doornum GJ; Kirnbauer R; Quint WG; Dillner J
    J Med Virol; 1995 Aug; 46(4):368-74. PubMed ID: 7595415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific serum IgG, IgM and IgA antibodies to human papillomavirus types 6, 11, 16, 18 and 31 virus-like particles in human immunodeficiency virus-seropositive women.
    Petter A; Heim K; Guger M; Ciresa-Kö Nig A; Christensen N; Sarcletti M; Wieland U; Pfister H; Zangerle R; Höpfl R
    J Gen Virol; 2000 Mar; 81(Pt 3):701-8. PubMed ID: 10675407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal immunization of mice with peptide having a cross-neutralization epitope on minor capsid protein L2 of human papillomavirus type 16 elicit systemic and mucosal antibodies.
    Kawana K; Kawana Y; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
    Vaccine; 2001 Jan; 19(11-12):1496-502. PubMed ID: 11163673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
    Viscidi RP; Ahdieh-Grant L; Schneider MF; Clayman B; Massad LS; Anastos KM; Burk RD; Minkoff H; Palefsky J; Levine A; Strickler H
    J Infect Dis; 2003 Dec; 188(12):1834-44. PubMed ID: 14673762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin A, G, and M responses to L1 and L2 capsids of human papillomavirus types 6, 11, 16, 18, and 33 L1 after newly acquired infection.
    van Doornum G; Prins M; Andersson-Ellström A; Dillner J
    Sex Transm Infect; 1998 Oct; 74(5):354-60. PubMed ID: 10195032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of serum antibodies against defined epitopes of human papillomavirus L1, E2, and E7 antigens and of HPV DNA with incident cervical cancer.
    Dillner L; Zellbi A; Avall-Lundqvist E; Heino P; Eklund C; Pettersson CA; Forslund O; Hansson BG; Grandien M; Bistoletti P
    Cancer Detect Prev; 1995; 19(5):381-93. PubMed ID: 7585724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners: a prospective study.
    Van Doornum GJ; Prins M; Juffermans LH; Hooykaas C; van den Hoek JA; Coutinho RA; Quint WG
    Genitourin Med; 1994 Aug; 70(4):240-6. PubMed ID: 7959707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hand-to-genital and genital-to-genital transmission of human papillomaviruses between male and female sexual partners (HITCH): a prospective cohort study.
    Malagón T; Louvanto K; Wissing M; Burchell AN; Tellier PP; El-Zein M; Coutlée F; Franco EL
    Lancet Infect Dis; 2019 Mar; 19(3):317-326. PubMed ID: 30745276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of immunoglobulin IgA and IgG against human papilloma virus.
    Gonçalves AK; Machado PR; de Souza LC; Costa AP; Gimenes F; Consolaro ML; Crispim JO; Eleutério J; Giraldo PC
    Viral Immunol; 2014 Nov; 27(9):471-7. PubMed ID: 25191973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of human papillomavirus type 16 DNA and of antibodies to human papillomavirus type 16 proteins in children.
    Mund K; Han C; Daum R; Helfrich S; Müller M; Fisher SG; Schiller JT; Gissmann L
    Intervirology; 1997; 40(4):232-7. PubMed ID: 9612724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of antibodies to L1, L2, and E4 proteins of human papillomavirus types 6, 11, and 16 by ELISA using synthetic peptides.
    Le Cann P; Chabaud M; Leboulleux D; Mougin C; Mayelo V; Legrand MC; Calvet C; Afoutou JM; Coll-Seck AM; Coursaget P
    J Med Virol; 1995 Apr; 45(4):410-4. PubMed ID: 7545211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus type 16 capsids expose multiple type-restricted and type-common antigenic epitopes.
    Heino P; Skyldberg B; Lehtinen M; Rantala I; Hagmar B; Kreider JW; Kirnbauer R; Dillner J
    J Gen Virol; 1995 May; 76 ( Pt 5)():1141-53. PubMed ID: 7537325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of human immunodeficiency virus type 1 status on human papillomavirus (HPV) prevalence and HPV antibodies in serum and cervical secretions.
    Marais DJ; Vardas E; Ramjee G; Allan B; Kay P; Rose RC; Williamson AL
    J Infect Dis; 2000 Oct; 182(4):1239-42. PubMed ID: 10979925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping of linear epitopes of human papillomavirus type 16: the L1 and L2 open reading frames.
    Dillner J; Dillner L; Utter G; Eklund C; Rotola A; Costa S; DiLuca D
    Int J Cancer; 1990 Mar; 45(3):529-35. PubMed ID: 1689705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus DNA and anti-HPV secretory IgA antibodies in cytologically normal cervical specimens.
    Veress G; Kónya J; Csiky-Mészáros T; Czeglédy J; Gergely L
    J Med Virol; 1994 Jun; 43(2):201-7. PubMed ID: 8083670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
    Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
    J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of genital human papillomavirus infection in a female adolescent population.
    Jamison JH; Kaplan DW; Hamman R; Eagar R; Beach R; Douglas JM
    Sex Transm Dis; 1995; 22(4):236-43. PubMed ID: 7482107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.